| N = 334 (100%) |
---|---|
Age (years) | 63.27545 ± 9.266274 |
Gender | Â |
Female | 158(47.30%) |
Male | 176(52.69%) |
Histology | Â |
Adenocarcinoma | 278(83.2%) |
LEP | 37(11.0%) |
ACI-PAP | 186(55.6%) |
MIP-SOL | 55(16.4%) |
Squamous cell carcinoma | 45(13.4%) |
Poor differentiated | 24(7.1%) |
Moderate/high differentiated | 21(6.2%) |
Mixed | 11(3.2%) |
Number of resected lymph nodes | 17.43413 ± 6.823394 |
Tumor diameter(mm) | 32.61677 ± 3.625463 |
Vascular invasion | Â |
Yes | 5(1.6%) |
No | 329(98.3%) |
Visceral pleural invasion | Â |
Yes | 124(37.12%) |
No | 210(62.87%) |
Adjuvant chemotherapy | Â |
Yes | 126(37.72%) |
No | 208(62.27%) |
Recurrence | Â |
Yes | 39(11.67%) |
No | 295(88.32%) |
Death | Â |
Yes | 15(4.2%) |
No | 319(95.7%) |